中外製薬株式会社
Japanese only中外製薬株式会社· Corporate Number: 5011501002900
About this English name
No English name available. Original Japanese name is shown.
Enforcement records (3)
- Jan 21, 2022承認Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
Approval regarding treatment for COVID-19 with the drug Actemra intravenous infusion. Today, approval was granted for the addition of indications and effects related to COVID-19 for the pharmaceutical product Actemra intravenous infusion.
- Nov 5, 2021特例承認医薬品医療機器等法Ministry of Health, Labour and Welfare
A special approval was granted under Article 14-3 of the Pharmaceuticals and Medical Devices Act regarding some changes to the manufacturing and marketing approval for a COVID-19 treatment drug.
- Jul 19, 2021特例承認医薬品医療機器等法Ministry of Health, Labour and Welfare
Special approval was granted under Article 14-3 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices for a treatment drug related to COVID-19.
Watch this company
Get an email when 中外製薬株式会社 has new enforcement actions or registry changes. Sign-in is via a one-time email link — no password required.
Language
日本語版を見る (Japanese)Registry data
- Corporate Number (法人番号)
- 5011501002900
- Registered address
- 東京都北区浮間５丁目５番１号
- Status
- Active
For compliance use
This profile aggregates public Japanese government records. Always cross-reference the Corporate Number when matching this entity in your systems — Japanese English company names are often inconsistent across sources.